Johnson & Johnson Shuts Australian Facility Amid Squeeze On Drug Markets

Health-care giant Johnson & Johnson (JNJ) is shutting a biotechnology research facility outside Sydney as part of a cost-cutting effort spurred on by challenging conditions in pharmaceutical markets.